The Opal patient engagement platform feautured in Oncopole's first blog post!

Quebec’s cancer research funding agency Oncopole has started a series of blog posts with its first featuring the Opal patient engagement platform, which is designed, developed and operated by the Kildea lab at the RI-MUHC.

The post is entitled “Transformer la recherche en réalité prometteuse – Le portail patient Opal : vers des soins de santé plus accessibles”.

Thank you to Oncopole for recognizing our work!

Link to Oncopole’s blog post